A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic modelCraig H. Moskowitz, Joachim Yahalom, Joseph R. Bertino et al.|Blood|2001Cited by 427
Ifosfamide, Carboplatin, and Etoposide: A Highly Effective Cytoreduction and Peripheral-Blood Progenitor-Cell Mobilization Regimen for Transplant-Eligible Patients With Non-Hodgkin's LymphomaCraig H. Moskowitz, Andrew D. Zelenetz, Joseph R. Bertino et al.|Journal of Clinical Oncology|1999Cited by 303
An Inv(16)(p13.3q24.3)-Encoded CBFA2T3-GLIS2 Fusion Protein Defines an Aggressive Subtype of Pediatric Acute Megakaryoblastic LeukemiaTanja A. Grüber, James R. Downing, Amanda Larson Gedman et al.|Cancer Cell|2012Cited by 276
High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: an intention-to-treat analysisTarun Kewalramani, Craig H. Moskowitz, Andrew D. Zelenetz et al.|Blood|2000Cited by 120
p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemiaNa Man, Stephen D. Nimer|JCI Insight|2021Cited by 19